Jorge Fragío | Rheumatology (@jorgefragio) 's Twitter Profile
Jorge Fragío | Rheumatology

@jorgefragio

MD, PhD | #Lupus #SLE and #ArtificialIntelligence

ID: 161213407

calendar_today30-06-2010 07:56:26

1,1K Tweet

542 Followers

764 Following

Raquel Rivera (@rrivera9) 's Twitter Profile Photo

Qué es el SITRAME? Nuevo síndrome autoinflamatorio descrito en adultos. Atentos a las características: semejan celulitis recurrentes sobre todo en tronco con fiebre #SCAEDV #Dermatologia

Qué es el SITRAME? Nuevo síndrome autoinflamatorio descrito en adultos. Atentos a las características: semejan celulitis recurrentes sobre todo en tronco con fiebre
#SCAEDV #Dermatologia
#i𝗚𝗡 (@ignabroomr) 's Twitter Profile Photo

¿POR QUÉ LOS CORREDORES "FITNESS" NUNCA MEJORAN? Me refiero a los gym-bros 💪🏻 Los que “salen a hacer cardio”. Los que dicen que “el cardio engorda”. Los que trotan 20’ en cinta para marcar six-pack. Y es que, no es igual entrenar atletismo que hacer cardio. Vamos a ver... 🧵👇🏻

¿POR QUÉ LOS CORREDORES "FITNESS" NUNCA MEJORAN?

Me refiero a los gym-bros 💪🏻
Los que “salen a hacer cardio”.
Los que dicen que “el cardio engorda”.
Los que trotan 20’ en cinta para marcar six-pack.

Y es que, no es igual entrenar atletismo que hacer cardio.

Vamos a ver... 🧵👇🏻
Dr. John Cush (@rheumnow) 's Twitter Profile Photo

FDA announced approval of Inebilizumab (Uplizna; Amgen), 1st approved Rx for IgG4-related disease (targets CD19+ B cells). IG4-related Dz is estimated to affect 20,000 in the USA. List price is $140,248.50 per dose, After two initial loading doses it is given q 6 mos.

FDA announced approval of Inebilizumab (Uplizna; Amgen), 1st approved Rx for IgG4-related disease (targets CD19+ B cells). IG4-related Dz is estimated to affect 20,000 in the USA. List price is $140,248.50 per dose, After two initial loading doses it is given q 6 mos.
Roxana González (@roxosler) 's Twitter Profile Photo

Encantada de haber participado en esta mesa compartida sobre #AR, hablando sobre los retos actuales que nos exigen mirar más allá de la inflamación. Excelentes moderadores y una compañera de lujo, Hye S. ¡Gracias! #SER2025 Soc.Esp.Reumatología

Encantada de haber participado en esta mesa compartida sobre #AR, hablando sobre los retos actuales que nos exigen mirar más allá de la inflamación. Excelentes moderadores y una compañera de lujo, <a href="/hyepark_reuma/">Hye S</a>. ¡Gracias! #SER2025 <a href="/SEReumatologia/">Soc.Esp.Reumatología</a>
Roxana González (@roxosler) 's Twitter Profile Photo

Year in Review #Basic by Dr. Tsokos #LUPUS2025 ✅NCF1H protects from virus but triggers lupus ✅Rab4A alters T cell mitochondria, reversed by rapamycin ✅UNC93B1 & TASL mutations drive early-onset SLE via TLR7/8 ✅Hormones modulate PTPN22: more severe lupus in males

Year in Review #Basic by Dr. Tsokos #LUPUS2025 
✅NCF1H protects from virus but triggers lupus
✅Rab4A alters T cell mitochondria, reversed by rapamycin
✅UNC93B1 &amp; TASL mutations drive early-onset SLE via TLR7/8
✅Hormones modulate PTPN22: more severe lupus in males
Roxana González (@roxosler) 's Twitter Profile Photo

#Basic by Dr. Tsokos #LUPUS2025 ✅IL-2 therapy expands tissue-homing Tregs:gut (CD38+),skin (HLA-DR+), inflammation (double+) ✅SLE patients show reduced vaccine response,esp. with anti-BAFF(↓B/Tfh priming) ✅Type I IFN triggers mitochondrial sensing & IL-1β release in monocytes

#Basic by Dr. Tsokos #LUPUS2025
✅IL-2 therapy expands tissue-homing Tregs:gut (CD38+),skin (HLA-DR+), inflammation (double+)
✅SLE patients show reduced vaccine response,esp. with anti-BAFF(↓B/Tfh priming)
✅Type I IFN triggers mitochondrial sensing &amp; IL-1β release in monocytes
Roxana González (@roxosler) 's Twitter Profile Photo

Gluconolactone restores immune balance by suppressing Th17 and promoting Tregs. 🔹Improves skin lesions in lupus-prone mice 🔹Reduces acanthosis and CLASI scores in cutaneous lupus patients after 2 weeks 🔹Modulates metabolic pathways (PPP) in Tregs #LUPUS2025

Gluconolactone restores immune balance by suppressing Th17 and promoting Tregs.
🔹Improves skin lesions in lupus-prone mice
🔹Reduces acanthosis and CLASI scores in cutaneous lupus patients after 2 weeks
🔹Modulates metabolic pathways (PPP) in Tregs #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

Lupus Nephritis & Fibrosis Hypoxia in tubular epithelial cells induces ADAM9 via HIF-1α ➡️activates TGF-β1 ➡️drives fibrosis in lupus nephritis 💡Targeting hypoxia-induced ADAM9 could limit renal damage and chronic progression in LN #LUPUS2025

Lupus Nephritis &amp; Fibrosis
Hypoxia in tubular epithelial cells induces ADAM9 via HIF-1α ➡️activates TGF-β1 ➡️drives fibrosis in lupus nephritis 💡Targeting hypoxia-induced ADAM9 could limit renal damage and chronic progression in LN #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

Neuroinflammation in #SLE Anti-NMDAR autoantibodies trigger hippocampal neuronal damage. Sustained inflammation is driven by the HMGB1–RAGE axis and reversed by LAIR-1 upregulation. ACE/AT1R inhibitors also prevent synaptic loss. #LUPUS2025

Neuroinflammation in #SLE
Anti-NMDAR autoantibodies trigger hippocampal neuronal damage. Sustained inflammation is driven by the HMGB1–RAGE axis and reversed by LAIR-1 upregulation. ACE/AT1R inhibitors also prevent synaptic loss. #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

Obinutuzumab➡️A type II anti-CD20 showed higher renal response rates in LN patients vs placebo in both NOBILITY (Ph II) and REGENCY (Ph III) trials, especially in serologically active patients and those with ⬆️proteinuria. Safety profile✅ Primary endpoints met✅ #LUPUS2025

Obinutuzumab➡️A type II anti-CD20 showed higher renal response rates in LN patients vs placebo in both NOBILITY (Ph II) and REGENCY (Ph III) trials, especially in serologically active patients and those with ⬆️proteinuria. Safety profile✅ Primary endpoints met✅ #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

SLE patients face a ⬆️ 2–3x higher 10-year atherosclerosis risk. Persistent remission & CVRF control slow plaque progression. SGLT2i reduce CV, renal & sepsis events in SLE+T2D. #LUPUS2025

SLE patients face a ⬆️ 2–3x higher 10-year atherosclerosis risk. 
Persistent remission &amp; CVRF control slow plaque progression. 
SGLT2i reduce CV, renal &amp; sepsis events in SLE+T2D. #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

Urinary proteomics in LN identifies 12-protein panels mirroring histological activity & predicting 1-year response. In silico analysis suggests IFN-stratified drug choices (mTORi, anti-CD19/CD38, BTKi) #LUPUS2025

Urinary proteomics in LN identifies 12-protein panels mirroring histological activity &amp; predicting 1-year response. In silico analysis suggests IFN-stratified drug choices (mTORi, anti-CD19/CD38, BTKi) #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

Repeat kidney biopsy in lupus nephritis? 🔹It distinguishes active inflammation from chronic damage. 🔹Only 44% of clinical remissions = histologic remission. 🔹Biopsy helps guide treatment decisions, including tapering. 🔹Biopsy-guided care = fewer flares. #LUPUS2025

Repeat kidney biopsy in lupus nephritis? 
🔹It distinguishes active inflammation from chronic damage.
🔹Only 44% of clinical remissions = histologic remission.
🔹Biopsy helps guide treatment decisions, including tapering.
🔹Biopsy-guided care = fewer flares. #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

Imaging (US & MRI) uncovers hidden inflammation in lupus arthritis. Subclinical synovitis is common, even in the absence of clinical arthritis. Both modalities detect structural changes that may reshape treatment decisions. #LUPUS2025

Imaging (US &amp; MRI) uncovers hidden inflammation in lupus arthritis. Subclinical synovitis is common, even in the absence of clinical arthritis. Both modalities detect structural changes that may reshape treatment decisions. #LUPUS2025
Roxana González (@roxosler) 's Twitter Profile Photo

Subclinical synovitis in #SLE is not benign, it predicts joint progression and damage. Despite unclear treatment guidelines, early detection via imaging may shift management strategies. #LUPUS2025

Subclinical synovitis in #SLE is not benign, it predicts joint progression and damage. Despite unclear treatment guidelines, early detection via imaging may shift management strategies. #LUPUS2025
José Morón (@jmgmoron) 's Twitter Profile Photo

¿Recordáis estas fotos de Alcaraz? Cuando perdió ante Goffin, en Miami, Carlitos se fue con su familia y amigos de vacaciones por México. Le llovieron palos por redes, sobre todo de aquellos que le decían que debía ponerse a entrenar. ¿Sabéis qué pasó? Ganó 22 de los

¿Recordáis estas fotos de Alcaraz?

Cuando perdió ante Goffin, en Miami, Carlitos se fue con su familia y amigos de vacaciones por México.

Le llovieron palos por redes, sobre todo de aquellos que le decían que debía ponerse a entrenar.

¿Sabéis qué pasó?

Ganó 22 de los
Umberto León Domínguez 🧠 🤖 (@umbertoleon) 's Twitter Profile Photo

Madre mía que buen artículo sobre la inhibición de pensamientos intrusivos a través de detener la recuperación de recuerdos... os explico cómo! El hilo que todo neuropsicólogx (y psicólogo clínico) necesitaba sin saberlo!

Madre mía que buen artículo sobre la inhibición de pensamientos intrusivos a través de detener la recuperación de recuerdos... os explico cómo!

El hilo que todo neuropsicólogx (y psicólogo clínico) necesitaba sin saberlo!